Member Info for Neavo246

Massively undervalued here, pleased to be invested

Thanks for the informative posts guys

Thanks LB

LB - what do you mean by iceberg ask ?

Many thanks !

Good to see a little break out here this afternoon. Was thinking of topping up this morning, typical! Not complaining though good luck all.

Evening Suffolk - do you know when the interview comes out ?

SR the first paragraph is an opinion; fair enough. The second paragraph is an agenda. Just pack it in with the cross ramping this is a decent board.

Their is an air of self-righteousness in the way ophidian posts that has started to polarise opinion. Starting a thread about yourself just reduces credibility further.

Cheers For the link Bid - great few days here

Thanks guys

Noships - I hope so ! Is that from a podcast or an article?

Bidnolid - completely agree. I got into this at 18p after seeing the potential of the IP and having respect for Ali Mortavazi. I do well out of following trusted CEOs through their careers. The informatics platform looks a solid foundation to commercialise as they establish the RNAi platform. Significant R&D spend of over £2.5m is very encouraging with Ali overseeing this.

I scan this board occasionally waiting for a bright poster to suggest future newsflow, but to no avail!

Don’t get me wrong I am not complaining at the excellent rise in share price. It has been a welcome surprise

Had a look into Jupiter - they have performed terribly over the last 3 years. Minimum contribution from PI of £1m. Must be a lot of unhappy campers.

Best of luck gents. Still retain a modest holding for the fun of it haha

I think this is a fair price for it at the moment. We don’t know size of orders/profit per test produced. Biosure’s turnover is under £1m as of 2019 on companies house; need to have a bit of realism.

Many have been stuck in this share for a long time. There have been layoffs, a significant cash burn and the pending court case. Many were 50-80% down. Do not blame anyone for derisking now many are back to even/humble profit.

Great minds, mucker

Thanks for posting these. Let’s be honest, these are pretty detailed and damning; there is truth in these reviews between the hyperbole. This is under a umbrella of a couple of things though; sites like Glassdoor are going to appeal most to dissenting voices. And by nature, manufacturing roles are always going to have high staff turnover when there is peak demand.

Clearly the company is flat out and very busy. Good for the mid term perhaps but sounds like they need to change their management approach pretty quickly.

A sincere thanks Glen -a good read and I will keep an eye out for your insight in the future.

Thanks Glen - I wasn’t aware of that, I just made an assumption, poor form. Hope to find an entry point next week. What is your target price for this? I would hope 200 is a realistic target by the turn of the year.